Tezspire (tezepelumab)

pCPA File Number: 22089
Negotiation Status:
Under consideration for negotiation
Indication(s):
severe asthma
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CADTH Project Number:
SR0731
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable